...
首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis of 7,8-(methylenedioxy)-1-phenyl-3,5-dihydro-4H-2, 3-benzodiazepin-4-ones as novel and potent noncompetitive AMPA receptor antagonists.
【24h】

Synthesis of 7,8-(methylenedioxy)-1-phenyl-3,5-dihydro-4H-2, 3-benzodiazepin-4-ones as novel and potent noncompetitive AMPA receptor antagonists.

机译:7,8-(亚甲基二氧基)-1-苯基-3,5-二氢-4H-2,3-苯并二氮杂-4-酮的合成作为新型和有效的非竞争性AMPA受体拮抗剂。

获取原文
获取原文并翻译 | 示例
           

摘要

A group of 7,8-(methylenedioxy)-1-phenyl-3,5-dihydro-4H-2, 3-benzodiazepin-4-ones was synthesized and assayed for antagonism of rat brain alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors expressed in Xenopus oocytes. The benzodiazepinones inhibited AMPA-activated membrane current responses in a manner consistent with noncompetitive, allosteric inhibition of the receptor-channel complex. The most potent compound in the series was 1-(4-aminophenyl)-7,8-(methylenedioxy)-3,5-dihydro-4H-2, 3-benzodiazepin-4-one (6), which had an IC50 of 2.7 microM. For comparison, the reference compound GYKI 52466 (2) had an IC50 of 6.9 microM. Compound 6 also had potent anticonvulsant activity in a mouse maximum electroshock-induced seizure (MES) assay: the ED50 was 2.8 mg/kg iv, whereas the ED50 for GYKI 52466 was 4.6 mg/kg iv. In contrast to a previous report, the 7,8-dimethoxy analogue of 6 was a low-potency AMPA antagonist (IC50 >100 microM) and weak anticonvulsant (ED50 >10 mg/kg iv). The benzodiazepinones described herein are potent noncompetitive AMPA receptor antagonists that could have therapeutic potential as anticonvulsants and neuroprotectants.
机译:合成了一组7,8-(亚甲基二氧基)-1-苯基-3,5-二氢-4H-2,3-苯并二氮杂-4-酮,并测定了对大鼠脑α-氨基-3-羟基-5的拮抗作用在非洲爪蟾卵母细胞中表达的-甲基异恶唑-4-丙酸(AMPA)受体。苯并二氮杂酮以与受体通道复合物的非竞争性变构抑制作用一致的方式抑制AMPA激活的膜电流反应。该系列中最有效的化合物是1-(4-氨基苯基)-7,8-(亚甲二氧基)-3,5-二氢-4H-2、3-苯并二氮杂-4--4-酮(6),IC50为2.7微米为了比较,参考化合物GYKI 52466(2)的IC50为6.9 microM。在小鼠最大电击诱发的癫痫发作(MES)分析中,化合物6还具有强大的抗惊厥活性:ED50为2.8 mg / kg iv,而GYKI 52466的ED50为4.6 mg / kg iv。与先前的报告相反,6的7,8-二甲氧基类似物是低效AMPA拮抗剂(IC50> 100 microM)和弱惊厥药(ED50> 10 mg / kg iv)。本文所述的苯并二氮杂酮是有效的非竞争性AMPA受体拮抗剂,可以作为抗惊厥药和神经保护药具有治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号